DIPROSALIC OINTMENT
Country: Singapore
Language: English
Source: HSA (Health Sciences Authority)
Patient Information leaflet
(PIL)
18-02-2013
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
BETAMETHASONE DIPROPIONATE 0.64MG/G EQV BETAMETHASONE
Available from:
MSD PHARMA (SINGAPORE) PTE. LTD.
ATC code:
D07XC01
Dosage:
0.50 mg/g
Pharmaceutical form:
OINTMENT
Administration route:
TOPICAL
Prescription type:
Prescription Only
Manufactured by:
S-P CANADA
Authorization date:
1990-04-20
Patient Information leaflet
DIPROSALIC® OINTMENT
Brand of betamethasone dipropionate and salicylic acid
FOR DERMATOLOGIC USE ONLY
DESCRIPTION: DIPROSALIC Ointment provides in each gram 0.64
mg of betamethasone
dipropionate, equivalent to 0.5 mg (0.05%) of betamethasone, and
30 mg (3%) of salicylic acid.
Salicylic acid is a keratolytic and antiseptic agent.
ACTIONS: Betamethasone dipropionate, a synthetic fluorinated corticosteroid, has anti-
inflammatory, antipruritic and
vasoconstrictive actions. DIPROSALIC Ointment demonstrates these
actions in a sustained
manner thereby permitting twice a day application.
Topical salicylic acid has keratolytic properties as well as
bacteriostatic and fungicidal actions.
INDICATIONS AND USAGE: DIPROSALIC Ointment
is indicated for the relief of the inflammatory
manifestations of hyperkeratotic and
dry corticosteroidresponsive dermatoses such as: psoriasis,
chronic atopic dermatitis, neurodermatitis
(lichen simplex chronicus), lichen planus, eczema
(including nummular eczema, hand eczema, eczematous dermatitis),
dyshidrosis (pompholyx),
seborrheic dermatitis of the scalp, ichthyosis vulgaris and
other ichthyotic conditions.
DOSAGE AND
ADMINISTRATION: A thin film of DIPROSALIC Ointment should
be applied to
cover completely the affected area, twice daily,
in the morning and at night. For some patients,
adequate maintenance therapy may be achieved with less
frequent application.
ADVERSE REACTIONS: Adverse reactions that have been reported with
the use of topical
corticosteroids include: burning, itching, irritation, dryness,
folliculitis, hypertrichosis, acneiform
eruptions, hypopigmentation, perioral dermatitis, allergic
contact dermatitis.
The following may occur more frequently with the use of occlusive dressings: maceration of the skin,
secondary infection, skin atrophy, striae and mil
Read the complete document
